Next-Generation Biomedical AI Paradigm
When cells undergo stressful, necrotic death, they release Damage-Associated Molecular Patterns (DAMPs). These alarm signals activate immune cells to initiate inflammation and repair.
Collect multi-omics patient data: genomics, proteomics, metabolomics.
AI identifies unique DAMP fingerprints for specific diseases.
ML models link signatures to clinical outcomes and responses.
Generate risk scores and therapy response predictions.
The most valuable data isn't foreign agents, but evidence of cellular damage. AI models must be retrained on this reality.
Effective AI must differentiate between acute (healing) and chronic (pathological) danger signals through temporal analysis.
The future is danger signal modulation, not immunosuppression. Opens new frontiers for AI-driven drug development.